WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy
- Conditions
- HypoxiaEsophagus CancerGastric CancerPeptic UlcerOesophagitis
- Registration Number
- NCT02436018
- Lead Sponsor
- RenJi Hospital
- Brief Summary
Low pulse oximetry is the most common adverse events during sedation for upper gastrointestinal endoscopy. The main reason is the glossoptosis after sedation. In present study a new designed nasopharyngeal airway embedded with jet ventilation catheter(WEI NASAL JET) will be utilized in order to reduce the hypoxia. At the same time the safety will be evaluated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1800
- patients undergoing upper gastrointestinal endoscopy
- age over 18 years old
- Signed informed consent form
- a blood coagulation dysfunction or have a tendency of nose bleeding
- a clear diagnosis of heart disease (heart failure, angina, myocardial infarction, arrhythmia, etc.)
- a clear diagnosis of lung disease (asthma, chronic obstructive pulmonary disease, pulmonary embolism, pulmonary edema, lung cancer)
- pregnant
- liver disease
- kidney disease
- increase in intracranial pressure
- emergency operation
- multiple trauma
- American Society of Anesthesiologists (ASA) Physical Status classification above IV
- with mouth, nose and throat infection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Low pulse oximetry incidence Patients will be followed for the duration of hospital stay, an expected average of 2 hours
- Secondary Outcome Measures
Name Time Method Other adverse events Patients will be followed for the duration of hospital stay, an expected average of 2 hours The adverse events according to the Adverse event reporting tool of the world SIVA International Sedation Task Force during upper gastrointestinal endoscopy will be recorded. Adverse events associated with jet ventilation also be recorded.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (3)
Shanghai Tongji Hospital
🇨🇳Shanghai, Shanghai, China
Renji hospital, School of Medicine, Shanghai Jiaotong University
🇨🇳Shanghai, Shanghai, China
Shanghai Pudong New Area People's Hospital
🇨🇳Shanghai, Shanghai, China
Shanghai Tongji Hospital🇨🇳Shanghai, Shanghai, ChinaXiaoqing Zhang, M.S.Contactxq_820175@163.com